Background: Understanding the impact of prevention programs on Clostridioides difficile
infection rates is important, and decisions on future program changes, including how to use …

Abstract Background Efforts to prevent Clostridioides difficile infection continue to expand
across the health care spectrum in the United States. Whether these efforts are reducing the …

Objective: To determine the attributable cost and length of stay of hospital-acquired
Clostridioides difficile infection (HA-CDI) from the healthcare payer perspective using linked …

We conducted a territorywide survey to investigate the epidemiology, risk factors, and
clinical outcomes of Clostridioides difficile infection (CDI) among hospitalized patients in …

Background Clostridioides difficile infection (CDI) is associated with high healthcare
demands and related costs. Aim To evaluate the healthcare and economic burden of CDI in …

Abstract Background Although hospital-onset Clostridioides difficile infection (CDI) is
associated with significant healthcare costs, the economic burden of CDI with onset in other …

Background Two vaccines against Clostridioides difficile infections (CDI) are currently in
phase III trials. To enable decision-making on their use in public health programs, national …

Objectives: The aim of this study was to make a comprehensive economic assessment of the
costs of hospital-acquired C. difficile infections (CDI). Methods: We carried out a …

Abstract Data from the National Inpatient Sample indicate that Clostridioides difficile
prevalence decreased from 10.1 (95% confidence interval [CI]= 9.9–10.3) to 8.6 (95% CI …

Objective: To conduct a systematic review of published real-world evidence describing the
cost and healthcare resource use for Clostridiodes difficile infection (CDI) in the United …